Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

9478	Companies
185488	Keywords
117863	Articles
99343	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 07/01/2025 at 13:15, 5 months 4 days ago

Bio Usawa becomes partner for the commercialization of FYB201/ BioUcenta™ (ranibizumab) across Sub-Saharan Africa
Bio Usawa partners with Formycon AG for the commercialization of FYB201/BioUcenta™ (ranibizumab) in Sub-Saharan Africa, expanding access to ophthalmic treatment for diabetic complications

Formycon AG Commercialization FYB201 Bio Usawa BioUcenta
BRIEF

published on 06/27/2025 at 15:56, 5 months 8 days ago

Formycon Successfully Places EUR 70 Million Bond Amid High Demand

Biosimilars Investor Interest Capital Market EUR 70 Million Formycon Bond
BRIEF

published on 06/27/2025 at 15:56, 5 months 8 days ago

Formycon place avec succès une obligation de 70 millions d'euros dans un contexte de forte demande

Marché Des Capitaux Biosimilaires Intérêt Des Investisseurs Liaison Formycon 70 Millions D'euros
PRESS RELEASE

published on 06/27/2025 at 15:51, 5 months 8 days ago

Formycon increases bond volume following oversubscription – Bond 2025/2029 with a volume of EUR 70 million successfully and entirely placed
Formycon AG successfully and entirely places EUR 70 million bond 2025/2029 following oversubscription, interest rate fixed at 7.00% p.a

Formycon AG Interest Rate Oversubscription EUR 70 Million Bond 2025/2029
BRIEF

published on 06/27/2025 at 15:50, 5 months 8 days ago

Formycon Secures EUR 70 Million Floating Rate Bond

Formycon AG Financial Issuance Biosimilar Development EUR 70 Million Bond Floating Rate Bond
BRIEF

published on 06/27/2025 at 15:50, 5 months 8 days ago

Formycon obtient une obligation à taux variable de 70 millions d'euros

Formycon AG Développement De Biosimilaires Émission Financière Obligation De 70 Millions D'euros Obligation À Taux Variable
PRESS RELEASE

published on 06/27/2025 at 15:45, 5 months 8 days ago

EQS-Adhoc: Formycon successfully places an EUR 70 million senior unsecured floating rate bond
Formycon AG successfully places EUR 70 million senior unsecured floating rate bond, issued with a maturity of 4 years, financed for biosimilar product portfolio development

Formycon AG Financial Market Senior Unsecured Bond Biosimilar Products EUR 70 Million
BRIEF

published on 06/26/2025 at 06:35, 5 months 9 days ago

Teva to Commercialize Formycon’s Biosimilar Fymskina® in Germany

Germany Biosimilar Formycon Teva Fymskina®
BRIEF

published on 06/26/2025 at 06:35, 5 months 9 days ago

Teva commercialisera le biosimilaire Fymskina® de Formycon en Allemagne

Allemagne Formycon Biosimilaire Teva Fymskina®
PRESS RELEASE

published on 06/26/2025 at 06:30, 5 months 9 days ago

Teva becomes secondary commercialization partner for Formycon's Stelara® biosimilar FYB202 (ustekinumab) under the brand name Fymskina® in Germany
Teva partners with Formycon for commercialization of Stelara biosimilar FYB202 (ustekinumab) as Fymskina in Germany. Market launch planned in Q3 2025

Biosimilar Formycon Teva Stelara Fymskina

Accesswire

Published on 12/05/2025 at 16:00, 11 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 26 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 26 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 36 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 46 minutes ago

Usha Resources Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:00, 11 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 11 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 11 minutes ago

Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 16:00, 11 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 15:47, 24 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc

Les Echos

Published on 12/05/2025 at 15:10, 1 hour ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 13 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 26 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 26 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE